NO20056042L - Forbindelser som er anvendelige til behandling av Alzheimers sykdom samt formuleringer inneholdende disse - Google Patents

Forbindelser som er anvendelige til behandling av Alzheimers sykdom samt formuleringer inneholdende disse

Info

Publication number
NO20056042L
NO20056042L NO20056042A NO20056042A NO20056042L NO 20056042 L NO20056042 L NO 20056042L NO 20056042 A NO20056042 A NO 20056042A NO 20056042 A NO20056042 A NO 20056042A NO 20056042 L NO20056042 L NO 20056042L
Authority
NO
Norway
Prior art keywords
alzheimer
disease
treatment
well
formulations containing
Prior art date
Application number
NO20056042A
Other languages
English (en)
Norwegian (no)
Inventor
Luisella Verotta
Gabriele Fontana
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of NO20056042L publication Critical patent/NO20056042L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/733—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having two rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20056042A 2003-05-30 2005-12-19 Forbindelser som er anvendelige til behandling av Alzheimers sykdom samt formuleringer inneholdende disse NO20056042L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001098A ITMI20031098A1 (it) 2003-05-30 2003-05-30 Composti utili nella terapia del morbo di alzheimer e formulazioni che li contengono
PCT/EP2004/005644 WO2004106275A2 (en) 2003-05-30 2004-05-26 Compounds useful in the therapy of alzheimer’s disease and formulations containing them

Publications (1)

Publication Number Publication Date
NO20056042L true NO20056042L (no) 2005-12-19

Family

ID=30131121

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20056042A NO20056042L (no) 2003-05-30 2005-12-19 Forbindelser som er anvendelige til behandling av Alzheimers sykdom samt formuleringer inneholdende disse

Country Status (16)

Country Link
US (1) US20070010507A1 (ja)
EP (1) EP1638914A2 (ja)
JP (1) JP2007505152A (ja)
KR (1) KR20060012316A (ja)
CN (1) CN1795158A (ja)
AU (1) AU2004242838A1 (ja)
BR (1) BRPI0410703A (ja)
CA (1) CA2527354A1 (ja)
DE (1) DE602004010100T2 (ja)
EC (1) ECSP056190A (ja)
IL (1) IL172213A0 (ja)
IT (1) ITMI20031098A1 (ja)
MX (1) MXPA05012826A (ja)
NO (1) NO20056042L (ja)
RU (1) RU2005136984A (ja)
WO (1) WO2004106275A2 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060287554A1 (en) * 2005-06-21 2006-12-21 Madsen Kevin K Process for producing inorganic salts of hop acids
WO2007035941A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal galantamine delivery system
EP2236160A3 (en) * 2009-03-31 2011-12-14 Sanovel Ilac Sanayi ve Ticaret A.S. Modified release dimebolin formulations
EP2483695A2 (en) * 2009-10-02 2012-08-08 Blanchette Rockefeller Neurosciences, Institute Abnormal alterations of pkc isozymes processing in alzheimer's disease peripheral cells
DE102010024105A1 (de) 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
CN108135872A (zh) * 2015-07-31 2018-06-08 约翰霍普金斯大学 用于治疗认知缺陷的谷氨酰胺拮抗剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU743956B2 (en) * 1998-02-13 2002-02-07 Dr. Willmar Schwabe Gmbh & Co Stable hyperforin salts, method for producing same and their use in the treatment of Alzheimer's disease
WO2000054785A2 (en) * 1999-03-15 2000-09-21 Shaman Pharmaceuticals, Inc. Stabilized bicyclo[3.3.1]nonenes and methods of use
PT1446136E (pt) * 2001-10-26 2010-12-29 Metaproteomics Llc Composições curcuminóides exibindo inibição sinérgica da expressão e/ou actividade de ciclooxigenase-2

Also Published As

Publication number Publication date
ITMI20031098A1 (it) 2004-11-30
BRPI0410703A (pt) 2006-06-13
ECSP056190A (es) 2006-08-30
RU2005136984A (ru) 2006-03-27
MXPA05012826A (es) 2006-02-13
IL172213A0 (en) 2009-02-11
JP2007505152A (ja) 2007-03-08
EP1638914A2 (en) 2006-03-29
WO2004106275A3 (en) 2005-03-17
DE602004010100T2 (de) 2008-09-18
KR20060012316A (ko) 2006-02-07
CA2527354A1 (en) 2004-12-09
US20070010507A1 (en) 2007-01-11
CN1795158A (zh) 2006-06-28
DE602004010100D1 (de) 2007-12-27
WO2004106275A2 (en) 2004-12-09
AU2004242838A1 (en) 2004-12-09
ITMI20031098A0 (it) 2003-05-30

Similar Documents

Publication Publication Date Title
NO20082530L (no) Imidazopyraziner som proteinkinaseinhibitorer
NO20071912L (no) Donepezilsalter egnet for fremstilling av farmasoytiske sammensetninger.
NO20055496L (no) Pyrazolokinazolinderivater, metoder for deres fremstilling og deres anvendelse som kinaseinhibitorer
NO20055092L (no) Substituerte pyrimidioner
GB0211649D0 (en) Organic compounds
NO20064347L (no) Substituerte 1,2,3,4-tetrahydroisokinolinderivater
MXPA04000920A (es) Derivados de aminoisoxazol activos como inhibidores de la cinasa.
CA2366932A1 (en) Cyclic protein tyrosine kinase inhibitors
DK0388827T3 (da) Anvendelse af 5-methyltetrahydrofolsyre, 5-formyltetrahydrofolsyre og deres farmaceutisk acceptable salte ved fremstilling af farmaceutiske præparater med kontrolleret frigivelse og aktive ved terapi af organiske mentale forstyrrelser, og de tilsvarende farmaceutiske præparater
NO20082092L (no) Pyrazolopyrimidiner som proteinkinaseinhibitorer
NO20030381L (no) Bicyklopyrazoler som er aktive som kinaseinhibitorer, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder slikeforbindelser
TW200615266A (en) Organic compounds
IL228952A0 (en) Pharmaceutical compositions comprising ferric citrate for reducing serum phosphate levels, and use thereof for the preparation of medicaments for treating or ameliorating calcium-associated disorders
NO20053855L (no) 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer.
TW200640486A (en) Composition
WO2008002245A3 (en) Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3)
NO20073059L (no) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
MXPA06000302A (es) Derivados de pirazolil-indol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden.
GB0222514D0 (en) Organic compounds
NO20065638L (no) Formuleringer med kontrollert frigivelse inneholdende vardenafil
BRPI0415953B8 (pt) formulação de dosagem de liberação controlada e conjunto de formas de dosagem de liberação controlada
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
DE602004014163D1 (de) Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken
NO20073176L (no) Nye medikamenter for behandling av luftveissykdommer
DE502005008971D1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht